Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research ...

Donanemab, the most effective treatment yet for the disease, has been banned on the health service despite regulators ...

Diagnosed with mild cognitive impairment (MCI) in 2018, Mr Almond, from Esher, took part in two 18-month trials for donanemab ...

The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.

The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...

North Korea’s decision to dispatch troops to help Russia subdue Ukraine may put another Kremlin ally, China, in a tough spot diplomatically. By David Pierson Sirajuddin Haqqani has tried to ...

This content was published on Oct 24, 2024 On Thursday, the Swiss Federal Railways presented its first fully renovated InterCity tilting train (ICN). Read more: Swiss railways presents first fully ...

Oct. 23, 2024 — Until now, researchers have been limited in developing photonic memory for AI processing -- gaining one important attribute like speed while sacrificing another like energy usage ...

The Central Bureau of Investigation (CBI) has moved the Supreme Court challenging the Karnataka government's decision to withdraw its consent to the probe agency for investigating a ...

IDF confirms the elimination of Hamas terrorist and UNRWA employee who on Oct 7 slaughtered civilians at a bomb shelter U.S. Special Envoy Amos Hochstein travels to Beirut for talks with Lebanese ...

Tesla CEO Elon Musk on Wednesday said the electric vehicle maker will roll out driverless ride-hailing services to the public in California and Texas next year, a claim likely to face significant ...